Medicinova (MNOV) Profit After Tax (2010 - 2026)
Medicinova (MNOV) posted quarterly Profit After Tax of -$2.8 million for Q4 2025, little changed year-over-year from -$2.8 million in Q4 2024, and up 8.13% quarter-over-quarter from -$3.1 million in Q3 2025.
Medicinova (MNOV) Profit After Tax (2010 - 2026) Analysis & Trends
Medicinova (MNOV) has reported Profit After Tax for 16 consecutive years, with -$2.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Profit After Tax changed 0.44% year-over-year to -$2.8 million; the TTM figure through Dec 2025 stood at -$12.0 million (down 8.66% YoY), while the FY2025 annual figure was -$12.0 million, down 8.58% from the prior year.
- Profit After Tax grew to -$2.8 million in Q4 2025 per MNOV's latest filing, from -$3.1 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$187799.0 in Q1 2021 and bottomed at -$4.3 million in Q2 2021.
- Historically, Profit After Tax has averaged -$2.8 million across 5 years, with a median of -$2.9 million in 2023.
- Annual changes were most pronounced in 2021 — Profit After Tax soared 93.08% — and 2022, when it tumbled 1703.21%.
- Medicinova's Profit After Tax stood at -$2.1 million in 2021, then tumbled by 45.35% to -$3.0 million in 2022, then jumped by 32.05% to -$2.1 million in 2023, then slumped by 37.26% to -$2.8 million in 2024, then rose by 0.44% to -$2.8 million in 2025.
- Business Quant data shows MNOV's Profit After Tax at -$2.8 million in Q4 2025, -$3.1 million in Q3 2025, and -$3.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -16.62 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Medicinova | 68.42 Mn | 68.42 Mn | 317,759.00 | -2.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.31 Mn |
| Dec 31, 2025 | -2.80 Mn |
| Sep 30, 2025 | -3.05 Mn |
| Jun 30, 2025 | -3.28 Mn |
| Mar 31, 2025 | -2.86 Mn |
| Dec 31, 2024 | -2.81 Mn |
| Sep 30, 2024 | -2.84 Mn |
| Jun 30, 2024 | -2.63 Mn |
| Mar 31, 2024 | -2.75 Mn |
| Dec 31, 2023 | -2.05 Mn |
| Sep 30, 2023 | -723,107.00 |
| Jun 30, 2023 | -2.87 Mn |
| Mar 31, 2023 | -2.92 Mn |
| Dec 31, 2022 | -3.02 Mn |
| Sep 30, 2022 | -3.65 Mn |
| Jun 30, 2022 | -4.03 Mn |
| Mar 31, 2022 | -3.39 Mn |
| Dec 31, 2021 | -2.08 Mn |
| Sep 30, 2021 | -3.58 Mn |
| Jun 30, 2021 | -4.28 Mn |